(Press-News.org) ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease.
"We are seeing powerful responses in a disease that historically has resisted every therapy," says Shaji Kumar, M.D., a Mayo Clinic Comprehensive Cancer Center hematologist and senior author of the study. "By recruiting T cells in two distinct ways at once, this dual-target antibody strategy can generate responses in patients who have had very few effective options."
The approach combines two engineered antibodies, talquetamab and teclistamab, that simultaneously engage T cells and force them to attack myeloma cells through two separate immune pathways. Unlike CAR-T cell therapy, which requires custom manufacturing, this regimen is delivered as a standard infusion-center injection.
In a trial involving 90 patients, 79% responded to treatment, and 54% achieved no detectable disease by imaging or blood testing. Among responders, nearly two-thirds maintained disease control at one year, a striking improvement for a subtype that typically carries a months-long prognosis.
This is the first large, prospective study defined specifically by PET/MRI scan and focused exclusively on true extramedullary myeloma, not a mix of para- and extramedullary disease. Serious side effects were common. Infection was one serious side effect and underscores the importance of comprehensive supportive care alongside immunotherapy.
The next big questions are whether this dual-target strategy can be moved earlier in the disease course, how safety can be optimized further through infection monitoring and prevention, and whether similar "two-locks, one-key" immune designs can be applied to other hard-to-treat cancers.
For a complete list of authors, disclosures and funding, review the study.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
About Mayo Clinic Comprehensive Cancer Center
Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Comprehensive Cancer Center is defining the cancer center of the future, focused on delivering the world's most exceptional patient-centered cancer care for everyone. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs in cancer detection, prevention and treatment to change lives.
END
Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy
2025-12-10
ELSE PRESS RELEASES FROM THIS DATE:
Cell-free DNA Could Detect Adverse Events from Immunotherapy
2025-12-10
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns Hopkins Kimmel Cancer Center have found.
In a Dec. 11 letter to the editor of the New England Journal of Medicine, the researchers described how they measured cell-free DNA to identify tissue damage to nine organs in a study involving 14 patients with solid tumors who received immune checkpoint inhibitor therapy, a treatment that helps boost the immune system’s ability to attack cancer. The test determined that the six patients in the cohort who had immune-related adverse events ...
American College of Cardiology announces Fuster Prevention Forum
2025-12-10
The American College of Cardiology is launching an early cardiovascular disease prevention education program to honor the contributions of Valentin Fuster, MD, PhD, MACC, and his lifelong commitment to establishing a culture of prevention in children. The Fuster Prevention Forum is an in-person educational course that will teach clinicians effective ways to educate children, parents and educators in their communities on nutrition, physical activity and emotional well-being.
“Valentin Fuster has a legacy of promoting heart healthy behaviors early ...
AAN issues new guideline for the management of functional seizures
2025-12-10
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, DECEMBER 10, 2025
Highlights:
A new guideline by the American Academy of Neurology says psychological interventions are possibly effective in helping people achieve freedom from functional seizures.
Functional seizures, previously known as psychogenic nonepileptic seizures or non-epileptic attack disorder, can look or feel like seizures from epilepsy or fainting, but they have their own typical features.
The guideline says appropriate treatment may decrease the frequency of functional seizures, decrease anxiety and improve quality of life.
The guideline recommends that antiseizure ...
Could GLP-1 drugs affect risk of epilepsy for people with diabetes?
2025-12-10
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, DECEMBER 10, 2025
Highlights:
GLP-1 drugs show a potential link to reduced epilepsy risk in people with type 2 diabetes.
People taking GLP-1 drugs were 16% less likely to develop epilepsy than those on DPP-4 inhibitors.
Semaglutide showed the strongest association with lower epilepsy risk among the GLP-1 drugs studied.
The study is preliminary and does not prove causation; randomized, controlled trials are needed to confirm these findings.
The drug tirzepatide was not included as it was introduced during the study period.
MINNEAPOLIS — A preliminary study of people with diabetes suggests ...
New circoviruses discovered in pilot whales and orcas from the North Atlantic
2025-12-10
A collaborative team of researchers (that includes students and senior researchers at Arizona State University (ASU), Coastal Carolina University, The University of the South in the US and researchers in Saint Vincent and the Grenadines, The University of the West Indies at Cave Hill (Barbados), University of Cape Town (South Africa), Institut Pasteur (France) have identified two previously unknown circoviruses in short-finned pilot whales and orcas from the Caribbean region of the North Atlantic Ocean. The findings represent the first detection of cetacean circoviruses in this region and ...
Study finds increase in risk of binge drinking among 12th graders who use 2 or more cannabis products
2025-12-10
BUFFALO, N.Y. – The cannabis marketplace continues to grow and evolve, offering consumers new ways to use cannabis — and new ways to combine it with other substances, such as alcohol. That practice can be particularly detrimental to adolescents, who are known to use both substances in high numbers.
And when it comes to cannabis use and binge drinking among high school seniors, modality matters, according to new research from the University at Buffalo finding that differing modes of cannabis consumption may be associated with risky alcohol use behaviors in this population.
The study is among the first to evaluate modes of cannabis use on binge drinking outcomes ...
New paper-based technology could transform cancer drug testing
2025-12-10
Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that enables tumor models to be grown, frozen, and stored for future use in cancer drug testing.
Spheromatrix is made from specially engineered filter paper patterned to support the growth of tumor spheroids in a controlled, reproducible manner. Unlike conventional approaches, which are expensive, complex, and cannot be preserved, this platform enables researchers to build biobanks of ...
Opioids: clarifying the concept of safe supply to save lives
2025-12-10
Canadian researchers want to clarify the concepts related to safe opioid supply to better assess their impact and guide public-health policies.
In Canada, thousands of people use contaminated street opioids. To reduce overdoses, the country has been experimenting for the past 10 years with the distribution of pharmaceutical opioids as an alternative to illicit drugs.
This method is often referred to as “safe supply” or “safer supply.”
What exactly do these terms, which emerged in the late 2010s and are central to Canadian harm reduction policies, mean?
In a study published in the International Journal of Drug Policy, ...
New species of tiny pumpkin toadlet discovered in Brazil highlights need for conservation in the mountain forests of Serra do Quiriri
2025-12-10
New species of tiny pumpkin toadlet discovered in Brazil highlights need for conservation in the mountain forests of Serra do Quiriri
Article URL: https://plos.io/48orUxO
Article title: A new species of Brachycephalus (Anura: Brachycephalidae) from Serra do Quiriri, northeastern Santa Catarina state, southern Brazil, with a review of the diagnosis among species of the B. pernix group and proposed conservation measures
Author countries: Brazil, U.S., Germany
Funding: The field work was funded by Fundação ...
Reciprocity matters--people were more supportive of climate policies in their country if they believed other countries were making significant efforts themselves
2025-12-10
Reciprocity matters--people were more supportive of climate policies in their country if they believed other countries were making significant efforts themselves, per survey of 4,000 Chinese, Indian, Japanese and US citizens.
Article URL: https://plos.io/4pfhbgj
Article Title: They reduce, we reduce: Perception of other countries’ climate effort predicts support for climate policies
Author Countries: China, Japan, Sweden
Funding: The work described in this study was supported by grants awarded to Kim-Pong Tam from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 16601122 ...